![Brett T. Staahl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brett T. Staahl
Fondateur chez
Scribe Therapeutics, Inc.
Health Technology
Profil
Brett T.
Staahl is the founder of Scribe Therapeutics, Inc. Dr. Staahl holds the title of Vice President-External Innovation at Scribe Therapeutics, Inc.
Postes actifs de Brett T. Staahl
| Sociétés | Poste | Début |
|---|---|---|
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops CRISPR-based genetic medicines | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Scribe Therapeutics, Inc.
Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops CRISPR-based genetic medicines | Health Technology |
